Table 2.
Characteristics of HD patients with and without plaque.
| Items | HD/nonplaque group (n = 149) | HD/plaque group (n = 119) | t/χ2 value | P value |
|---|---|---|---|---|
| Age, years | 48.3 ± 10.9 | 49.3 ± 10.9 | 0.773 | 0.440 |
| Gender, male/female | 32/28 | 30/23 | 0.082 | 0.774 |
| Dialysis duration, months | 44.5 ± 30.8 | 47.7 ± 34.6 | 0.787 | 0.432 |
| Smoking, no. (%) | 16 (26.7) | 14 (26.4) | 0.181 | 0.671 |
| Diabetes, no. (%) | 11 (18.3) | 10 (18.9) | 1.064 | 0.302 |
| NLR | 2.38 ± 0.63 | 4.59 ± 1.72a | 14.484 | 0.000 |
| KT/V | 1.36 ± 0.28 | 1.36 ± 0.29 | 0.293 | 0.770 |
| Hb, g/L | 115.5 ± 12.9 | 114.2 ± 12.5 | 0.840 | 0.402 |
| Alb, g/L | 36.4 ± 3.6 | 36.2 ± 3.4 | 0.438 | 0.662 |
| ALT, U/L | 15.2 ± 6.0 | 14.6 ± 5.5 | 0.779 | 0.437 |
| AST, U/L | 14.6 ± 6.8 | 13.9 ± 5.5 | 0.940 | 0.348 |
| TG, mmol/L | 1.89 ± 1.26 | 1.72 ± 1.05 | 1.141 | 0.255 |
| Tch, mmol/L | 4.31 ± 0.95 | 4.15 ± 0.74 | 1.561 | 0.120 |
| LDL-C, mmol/L | 2.26 ± 0.65 | 2.22 ± 0.61 | 0.466 | 0.642 |
| hsCRP, mmol/L | 3.06 ± 1.88 | 7.09 ± 3.53a | 11.958 | 0.000 |
| Cr, mol/L | 917.0 ± 167.6 | 909.3 ± 168.9 | 0.372 | 0.710 |
| BUN, mmol/L | 25.0 ± 5.8 | 24.6 ± 6.1 | 0.588 | 0.557 |
| Ca, mmol/L | 2.28 ± 0.31 | 2.30 ± 0.35 | 0.513 | 0.608 |
| P, mmol/L | 1.96 ± 0.59 | 1.89 ± 0.62 | 1.023 | 0.307 |
| iPTH, pg/ml | 274.6 ± 126.4 | 265.4 ± 125.3 | 0.590 | 0.556 |
| RASI, no. (%) | 43 (71.7) | 42 (79.2) | 0.285 | 0.593 |
| CCB, no. (%) | 45 (75.0) | 43 (81.1) | 0.691 | 0.406 |
| β-Blocker, no. (%) | 17 (28.3) | 17 (32.1) | 2.325 | 0.127 |
Values are means ± SD, unless specified otherwise.
a P < 0.01, compared with HD/nonplaque group.
NLR: neutrophil to lymphocyte ratio; Hb: hemoglobin; Alb: albumin; ALT: alanine transaminase; AST: aspartate aminotransferase; TG: triglyceride; Tch: total cholesterol; LDL-C: low density lipoprotein-cholesterol; hsCRP: high sensitivity C reactive protein; Cr: creatinine; BUN: blood urea nitrogen; Ca: calcium; P: phosphorus; iPTH: intact parathyroid hormone; RASI: renin angiotensin system inhibitor; CCB: calcium channel blocker; β-blocker: β-receptor blocker.